Bullboard - Stock Discussion Forum Phio Pharmaceuticals Corp PHIO

Healthcare Biotechnology

Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. The Company's INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. It is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or... see more

Add To Watchlist

NDAQ:PHIO - Post Discussion

Phio Pharmaceuticals Corp > Intratumoral Injection of Phio's PH-762 significantly inhibi

View:

Post by whytestocks on Apr 22, 2024 1:45pm

Intratumoral Injection of Phio's PH-762 significantly inhibi

Breaking News: $PHIO Intratumoral Injection of Phio's PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells | Benzinga-Injection in murine tumors shows the compound is well tolerated-Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for tr...PHIO - Intratumoral Injection of Phio's PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells | Benzinga